ljc 10627 has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikawa, K; Kameda, K; Kobayashi, M; Miki, M; Morikawa, N | 1 |
| Ikawa, K; Ikeda, K; Kobayashi, M; Miki, M; Morikawa, N; Nishimura, S | 1 |
1 trial(s) available for ljc 10627 and Body Weight
| Article | Year |
|---|---|
Population pharmacokinetics and pharmacodynamics of biapenem in paediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child; Child, Preschool; Creatinine; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa; Streptococcus pneumoniae; Thienamycins | 2008 |
1 other study(ies) available for ljc 10627 and Body Weight
| Article | Year |
|---|---|
[Dosing regimen rationalization of biapenem in pediatric patients: use of Monte Carlo simulation].
Topics: Adolescent; Anti-Infective Agents; Body Weight; Child; Child, Preschool; Creatinine; Drug Resistance, Bacterial; Female; Humans; Male; Metabolic Clearance Rate; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa; Regression Analysis; Streptococcus pneumoniae; Thienamycins | 2009 |